Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel

In June 2024, a group of 12 experts in the respiratory syncytial virus (RSV) field representing a cross-section of healthcare provider types who treat and care for pregnant individuals and infants, assembled to discuss the implementation of a broad infant prophylaxis program with nirsevimab in Ontar...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Human vaccines & immunotherapeutics 2024-12, Vol.20 (1), p.2429236
Hauptverfasser:	Paes, Bosco, Brown, Vivien, Courtney, Erin, Fleischer, Erin, Guy, Fiona, Lau, Eddy, Mills, Allan, Toole, Julie, Bardan, Meagan, Wong, Cynthia, Lam, Gary, Smith, Graeme N
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - administration & dosage Female Humans Infant Ontario Pregnancy Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Virus, Human - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!